Making treatment of rare blood disorder more affordable, effective

A research team has defined a possible new way to fight a disease that is currently treatable only with the most expensive drug available for sale in the United States. The strategy, based on the oldest part of the human immune system -- called complement -- could turn out to be less costly and more effective for the majority of patients with the rare blood disorder called aroxysmal nocturnal hemoglobinuria.